Perkins Investment Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$403K Sell
4,100
-700
-15% -$66.7K 0.01% 233
2016
Q4
$441K Buy
+4,800
New +$414K 0.01% 224
2015
Q3
Sell
-6,115
Closed -$443K 245
2015
Q2
$443K Buy
6,115
+2,515
+70% +$186K 0.01% 237
2015
Q1
$277K Sell
3,600
-1,300
-27% -$93.1K ﹤0.01% 253
2014
Q4
$329K Buy
4,900
+500
+11% +$31.6K ﹤0.01% 252
2014
Q3
$267K Sell
4,400
-7,200
-62% -$444K ﹤0.01% 236
2014
Q2
$681K Sell
11,600
-790,027
-99% -$46.3M 0.01% 239
2014
Q1
$46.4M Sell
801,627
-444,785
-36% -$23.8M 0.36% 90
2013
Q4
$66.7M Sell
1,246,412
-697,579
-36% -$41.4M 0.46% 83
2013
Q3
$120M Sell
1,943,991
-377
-0% -$22.6K 0.83% 46
2013
Q2
$118M Buy
+1,944,368
New +$116M 0.8% 46

Other funds holding DGX

Perkins Investment Management's DGX Position: Q1 2017 in Review

Perkins Investment Management reduced its Quest Diagnostics (DGX) stake by 15% in Q1 2017, selling an estimated $66.7K and leaving 4,100 shares worth $403K. The position accounts for 0.01% of the portfolio, ranked #233.

Perkins Investment Management first reported a position in DGX in Q2 2013 and has held it in 11 quarters since. The position peaked at $120M in Q3 2013. 614 funds tracked by Wall St. Rank hold DGX as of Q1 2017.

  • Perkins Investment Management held 4,100 shares of Quest Diagnostics worth $403K as of Q1 2017.
  • Perkins Investment Management sold 700 Quest Diagnostics shares in Q1 2017, an estimated $66.7K.
  • Quest Diagnostics made up 0.01% of Perkins Investment Management's portfolio in Q1 2017, its #233 holding.
  • Perkins Investment Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 11 quarters since.
  • Perkins Investment Management's Quest Diagnostics position peaked at $120M in Q3 2013.
  • 614 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2017.

Based on Perkins Investment Management's 13F filing for Q1 2017, filed 15 May 2017.